Clinical News: Page 1734

Siemens revenue, profit rise in Q4
By AuntMinnie.com staff writers
Strong earnings performance in its imaging and therapy systems businesses helped Siemens Healthcare to an increase in profit in its fiscal fourth quarter.
November 7, 2012
Radcal prepares RSNA launch of x-ray meters
By AuntMinnie.com staff writers
X-ray measurement technology developer Radcal will debut its family of diagnostic x-ray meters at the upcoming 2012 RSNA meeting in Chicago.
November 7, 2012
IMS inks U.S. sales deal with Fischer
By AuntMinnie.com staff writers
Italian women's imaging vendor Internazionale Medico Scientifica (IMS) has named Fischer Medical Technologies as the exclusive U.S. distributor for Giotto products.
November 7, 2012
Road to RSNA 2012: Molecular Imaging Preview
By Wayne Forrest
For molecular imaging, PET/MRI undoubtedly will garner considerable attention at the 2012 RSNA meeting in Chicago, as the hybrid modality gains interest with each new study that exalts its clinical potential. Preview the noteworthy molecular imaging and nuclear medicine scientific papers that will cover a wide range of clinical applications which will evaluate and benefit patient outcomes.
November 7, 2012
Road to RSNA 2012: Molecular Imaging Preview
FDG-PET and MRI could find keys to Alzheimer's
By Wayne Forrest
Thursday, November 29 | 11:30 a.m.-11:40 a.m. | SSQ14-07 | Room S504CDIn this study, researchers from the University of Washington used MRI, including diffusion-tensor imaging, and FDG-PET to discover different correlations across imaging biomarkers and brain regions in patients with cognitive impairment.
November 7, 2012
PET/MRI tops PET/CT in abdominopelvic lesion conspicuity
By Wayne Forrest
Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK08-09 | Room S504CDPET/MRI with ultrafast gradient-recalled echo and spin-echo sequences is superior to PET/CT for lesion conspicuity, thus potentially improving therapy for patients with abdominopelvic cancer, according to a study by Swiss researchers.
November 7, 2012
FDG-PET/CT helps assess pancreatic cancer recurrence
By Wayne Forrest
Wednesday, November 28 | 11:30 a.m.-11:40 a.m. | SSK13-07 | Room S505ABFDG-PET/CT has "excellent accuracy" in detecting a recurrence following resection of pancreatic cancer, and maximum standardized uptake values can be used in determining the prognosis of these patients, according to researchers from India.
November 7, 2012
FDG-PET/CT plays key role in treatment outcomes of prostate cancer
By Wayne Forrest
Wednesday, November 28 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABA preliminary study by researchers at the University of Southern California suggests that FDG-PET/CT provides unique prognostic information on outcomes for men with castrate-sensitive metastatic prostate cancer who are undergoing various forms of hormonal treatment.
November 7, 2012
Virtual FDG-PET/CT software shows hard-to-find malignancies
By Wayne Forrest
Wednesday, November 28 | 10:30 a.m.-10:40 a.m. | SSK13-01 | Room S505ABResearchers from the University of Düsseldorf in Germany have developed virtual FDG-PET/CT panendoscopy software for the upper airways that they say can detect pharyngeal and laryngeal malignancies.
November 7, 2012
DOTATATE-PET/CT helps detect pancreatic neuroendocrine tumors
By Wayne Forrest
Monday, November 26 | 11:50 a.m.-12:00 p.m. | SSC13-09 | Room 505ABIn this retrospective study from University of Munich Hospital, researchers found that DOTATATE-PET/CT detects pancreatic neuroendocrine tumors better than MRI.
November 7, 2012
Microbubble US helps early assessment of liver dysplasia
By Wayne Forrest
Monday, November 26 | 11:30 a.m.-11:40 a.m. | SSC09-07 | Room S504CDIn this presentation, German researchers will discuss their preliminary success with an ultrasound contrast agent -- known as BR55 -- that uses microbubbles targeting vascular endothelial growth factor receptor 2 to assess liver dysplasia.
November 7, 2012
PET/MRI outshines PET/CT in lesion detection
By Wayne Forrest
Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC13-04 | Room S505ABPET/MRI showed superior lesion detectability compared to contrast-enhanced PET/CT in this study from King Fahad Specialist Hospital in Dammam, Saudi Arabia. Based on the results, researchers concluded that PET/MRI may be useful for abdominal lesion staging while sparing patients from contrast media.
November 7, 2012
Previous Page
Page 1734 of 3659
Next Page